Biotech · Private company
Transposon Therapeutics, Inc.
Track this companyFree. Adds Transposon Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- TPN-101, 100 mg/dayPhase 2 · Progressive Supranuclear PalsyClinicalTrials.gov · fetched Nov 12, 2026
- TPN-101, 200 mg/dayPhase 2 · Progressive Supranuclear PalsyClinicalTrials.gov · fetched Nov 12, 2026
- TPN-101, 400 mg/dayPhase 2 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- TPN-101, 400 mg/dayPhase 2 · Progressive Supranuclear PalsyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)PHASE2 · COMPLETED · started Dec 12, 2021ClinicalTrials.gov NCT04993768 · fetched Nov 12, 2026
- A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTDPHASE2 · COMPLETED · started Oct 1, 2021ClinicalTrials.gov NCT04993755 · fetched Nov 12, 2026